Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Groupe D'etude Therapeutique Des Affections Inflammatoires Digestives

Clinical trials sponsored by Groupe D'etude Therapeutique Des Affections Inflammatoires Digestives, explained in plain language.

Trials to join now! 1 Not yet recruiting 1

Can mirikizumab mend the gut? new trial aims for deep healing in Crohn's

Disease control Not yet recruiting

This study tests whether the drug mirikizumab can help heal damage deep in the gut of people with Crohn's disease. About 110 adults with active Crohn's will receive the drug and be checked with MRI scans. The goal is to see if the drug can reduce inflammation and improve symptoms…

Phase: PHASE4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control

Last updated Apr 30, 2026 15:50 UTC